CD
Charles Duncan Cantor Fitzgerald Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Inovio Pharmaceuticals
INO
$146M
| $2.75 | $144 |
5,136%
upside
| Neutral |
28 Sep ‘20
5 years ago |
|
27
Geron
GERN
$868M
| $1.36 | $4 |
194%
upside
| Overweight |
1 Jun ‘20
5 years ago |
|
|
TVRD
28
Tvardi Therapeutics, Inc. Common Stock
TVRD
$278M
| $31.82 | $1,440 |
4,425%
upside
| Overweight |
19 May ‘20
5 years ago |
|
29
Halozyme
HALO
$8.87B
| $76.07 | $39 |
49%
downside
| Overweight |
4 May ‘20
5 years ago |
|
30
Corcept Therapeutics
CORT
$7.51B
| $71.73 | $15 |
79%
downside
| Neutral |
21 Feb ‘20
5 years ago |
|